Tuesday, August 25, 2020

Regenerative Medicine: Does BioMarin Complete Response Letter Change The Outlook?

2018 product approvals for gene therapy included Luxturna, Yescarta and Kymriah. The report concluded there were: 341 Phase I programs including ...
http://dlvr.it/RfLmgD
-

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)

2 muggers captured by RU students on campus - UNB

Rayhanul Ferdous, a student of Genetic Engineering and Biotechnology department who had his phone stolen told UNB: “I was walking on the eas...